Rhythm Pharmaceuticals Inc. is a global biopharmaceutical company committed to transforming the lives of patients with rare neuroendocrine diseases. The company focuses on advancing care and precision medicines that address the root causes of these diseases. It is actively involved in research and development, clinical trials, and developing a portfolio of treatments for conditions such as hyperphagia and obesity. Rhythm Pharmaceuticals aims to provide stigma-free care and improve the quality of life for patients with rare diseases, offering treatments like IMCIVREE® (setmelanotide) to address specific genetic deficiencies and meet the needs of affected patients, including young children.